University of California, Berkeley biochemist Jennifer Doudna won the 2020 Nobel Prize in Chemistry alongside Emmanuelle Charpentier for their pioneering work on CRISPR-Cas9. This revolutionary ...

Jennifer Doudna, a UC Berkeley biochemist who shared the 2020 Nobel Prize in Chemistry for the invention of CRISPR-Cas9 ...

Scribe Therapeutics, co-founded by Jennifer Doudna, is reducing staff, the latest layoffs among companies focused on CRISPR ...

Drs Emmanuelle Charpentier and Jennifer Doudna have won this year’s Nobel Prize for chemistry in recognition of their work on the gene-editing technology CRISPR/Cas9. Charpentier – currently ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team ...

The pharmaceutical industry is buzzing with innovation, driven by the need for new treatments, tackling unmet medical ...

Researchers at the Experimental and Clinical Research Center in Berlin are developing a targeted treatment for muscular ...

ECRC researchers developed a CRISPR-based gene therapy targeting dysferlin mutations in muscular dystrophy. By editing and ...

Back in 2014, CRISPR and its associated Cas proteins were mostly limited to academic research, generating a lot of excitement ...

The pharmaceutical industry is buzzing with innovation, driven by the need for new treatments, tackling unmet medical ...